Compare Banco Santander SA (SAN) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Santander SA vs Stryker Corporation — how do they compare? Banco Santander SA trades at $13.49 (market cap $192.86B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Banco Santander SA is the larger of the two by market cap, and Banco Santander SA pays the higher dividend (2.06%). Which is the better fit depends on your goals — on Pluang, investors hold Banco Santander SA for 55 Days and Stryker Corporation for 21 Days on average.
| SAN | SYK | |
|---|---|---|
Market Cap | $192.86B | $106.24B |
Volume | 10,644,519 | 2,982,001 |
Sector | Financials | Health |
52-Week High | $15.05 | $388.35 |
52-Week Low | $9.65 | $269.75 |
Typical Hold Time | 55 Days | 21 Days |
Enterprise Value | $360.86B | $117.70B |
Dividend Yield | 2.06% | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Banco Santander (SAN) trades at $13.48, down 1.32% with bearish technical signals despite strong fundamentals. The stock shows mixed earnings performance with Q1 2026 beat but Q2 miss, while maintaining robust profitability with 26.25% net margin and 16.07% ROE. Recent developments include the completed Webster Financial acquisition expanding U.S. presence and record quarterly profits reported in Q2 2026.
SAN presents a value opportunity with reasonable P/E of 13.55 and strong analyst support (64% buy ratings), though negative cash flow trends and declining operating cash flow from $56.7B in 2021 to -$24.2B in 2024 raise concerns. The Webster integration execution and European banking sector volatility represent key near-term risks.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
